Low vitamin D levels have been associated with infectious disease such as tuberculosis (1) and autoimmune disorders such as rheumatoid arthritis (2) . The expression of the vitamin D-receptor on cells of the innate and adaptive immune system implicates a role for vitamin D in immune function. Interleukin-6 (IL-6), an immune function marker, is an inflammatory cytokine whose production by human monocytes is inhibited by vitamin D in vitro (3) . The present study aimed to identify whether there are any changes in IL-6 concentrations during the winter months and the effect of vitamin D3 supplementation on IL-6 in South Asian and Caucasian women living in the UK.
Low vitamin D levels have been associated with infectious disease such as tuberculosis (1) and autoimmune disorders such as rheumatoid arthritis (2) . The expression of the vitamin D-receptor on cells of the innate and adaptive immune system implicates a role for vitamin D in immune function. Interleukin-6 (IL-6), an immune function marker, is an inflammatory cytokine whose production by human monocytes is inhibited by vitamin D in vitro (3) . The present study aimed to identify whether there are any changes in IL-6 concentrations during the winter months and the effect of vitamin D3 supplementation on IL-6 in South Asian and Caucasian women living in the UK.
A total of 70 subjects (South Asian n = 29, Caucasian n = 41) were selected from the D2-D3 study (4) based on the greatest 25-hydroxyvitamin D (25OHD) changes across the 12 week winter intervention period. Plasma samples were taken at baseline, 6 and 12 weeks but only those from visit 1 (baseline) and visit 2 (6 weeks) were analysed in this study. IL-6 was quantified using highsensitivity enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN, USA) and all standards and samples were plated in duplicate. Serum 25OHD levels had previously been determined by HPLC-MS/MS and were therefore available for use in this study. The D2-D3 study had ethical approval from both the South-East Coast (Surrey) NHS Research Ethics Committee (NHS REC No. 11/LO/0708) and the University of Surrey Ethics Committee (Fast-Track EC/2011/97/FHMS).
In the placebo group, IL-6 concentration did not change significantly from visit 1 to visit 2 for either the South Asian or Caucasian women. Supplementation with vitamin D3 did not significantly affect IL-6 concentration from visit 1 to visit 2 in either the South Asian or Caucasian women (Table 1) . 25OHD levels decreased significantly in the South Asian and Caucasian women taking the placebo and increased significantly in the women taking vitamin D3 ( Table 2 ).
The present study shows no significant change in IL-6 levels across the winter and no effect of vitamin D3 supplementation on IL-6 levels despite the significant change in vitamin D status of women in the D2-D3 study (4) . The present study supports a meta-analysis which found that vitamin D supplementation had no significant effect on IL-6 concentrations (5) as well as a 12 week study that showed no effect of calcium/vitamin D3 treatment on IL-6 concentrations (6) . Although these findings do not support a beneficial role for vitamin D with respect to IL-6 concentrations, new data in our labs with regard to IL-8 may warrant further study (7) . Table 1 . Interleukin-6 (IL-6) concentrations at visit 1 (V1) and visit 2 (V2).
Placebo
Vitamin D3 SA (n = 11) CA (n = 23) SA (n = 18)
IQR = Interquartile range, SA = South Asian, CA = Caucasian. 
